|
Center
for Drug Evaluation &
Research (CDER) News |
Center
for Biologics Evaluation
&
Research (CBER) |
Center
for Device &
Radiological
Health (CDRH) |
Federal Register -
Meetings, Notices, & Rule Changes |
|
January
23, 2009
January
22, 2009
January
21, 2009
-
Drugs Shortages: Current Drug
Shortages; Leucovorin
(updated)
-
New
and Generic Drug Approvals
-
Amoxicillin
Tablets, Dava
Pharmaceuticals, Inc.,
Approval
-
Infuvite Adult
(alpha-tocopherol, acetate,
ascorbic acid, biotin,
cholecalciferol,
cyanocobalamin, dexpanthenol,
folic acid, niacinamide,
pyridoxine hydrochloride,
riboflavin phosphate sodium,
thiamine hydrochloride,
vitamin a palmitate and
vitamin k) I.V. Injection,
Sandoz Canada Inc., Control
Supplement
-
Levetiracetam
Oral Solution, Cypress
Pharmaceutical, Inc.,
Approval
-
Levetiracetam
Oral Solution, Actavis Mid
Atlantic LLC, Approval
-
Levetiracetam
Tablets, InvaGen
Pharmaceuticals, Inc.,
Approval
-
Levetiracetam
Tablets, Teva
Pharmaceuticals, Approval
-
Levetiracetam
Tablets, Wockhardt Ltd.,
Approval
-
Nexium IV
(esomeprazole sodium)
Intravenous Injection,
AstraZeneca LP, Labeling
Revision
-
Nexium
(esomeprazole magnesium)
Delayed-Release Capsules,
AstraZeneca LP, Labeling
Revision
-
Pediatric Exclusivity Labeling
Changes
(updated)
CDER
Drug Links
|
|
|
January 23, 2009 |
 |
Obstetrics and Gynecology
Devices Panel Advisory
Meeting, December 11, 2008 -
Transcripts
 |
Medical Device Links
|
|
This
Week
Rule Changes:
21 CFR Parts
NONE
CFR
Changes since April 1st. |
|
Friday,
Jan. 23, 2009 |
NONE
|
|
Thursday,
Jan. 22, 2009 |
NOTICES
Compliance Policy Guide Sec.
540.370–Fish and Fishery
Products–Decomposition;
Availability,
4039–4040 [E9–1142]
[TEXT] [PDF]
|
|
Wed. Jan.
21, 2009 |
NOTICES
Draft Guidance for Industry
on Animal Models:
Essential
Elements to Address Efficacy
Under the Animal Rule ,
3610–3611 [E9–936]
[TEXT] [PDF]
Draft Guidance for Industry:
Citizen
Petitions and Petitions for
Stay of Action Subject to
Section 505(q) of the
Federal Food, Drug, and
Cosmetic Act; Availability ,
3611–3614 [E9–937]
[TEXT] [PDF]
Final Guidance for Sponsors,
Industry, Researchers,
Investigators, and Food and
Drug Administration Staff:
Certifications
to Accompany Drug,
Biological Product, and
Device
Applications/Submissions;
Compliance, etc. ,
3614–3615 [E9–1183]
[TEXT] [PDF]
Report of Quantitative Risk
and Benefit Assessment of
Commercial Fish Consumption,
etc.; Availability ,
3615–3617 [E9–1081]
[TEXT] [PDF]
Risk Assessment of the
Public Health Impact From
Foodborne Listeria
Monocytogenes in Some
Ready–to–Eat Foods, etc.
3617–3619 [E9–938]
[TEXT] [PDF]
|
|
Tuesday,
Jan. 20, 2009 |
NONE
|
|
Monday,
Jan. 19, 2009 |
|
NONE
|
|
|
|
.jpg)

EU - US - ICH GMP
Combination Product
handbook |
|
US GMP Training Booklet |
|
Std. GMPs
- Parts 11, 210, 211, 820 &
ICH Q7 |
|
Med. Device - 11, 50,
54, 56, 807, 812, 814, 820,
510k/PMA |
|
Clinical GCP - Parts 11,
50, 54, 56, 312, 314 & ICH
E2A & E6 |
|
Multi-US GMPs 11, 58,
210/211, 600, 601, 610
& 820 |
|
Parts 210/211 - Drug
GMPs |
|
>210/211
with Part 11 |
|
>210/211
with Part 820 |
|
>210/211
with Parts 820 & 11 |
|
>210/211
w/ Keyword Index |
Part 820
Quality Systems Regs
|
|
Part 58 - GLP Good
Lab. Practice |
Part 11
- Electronic Records w/
Scope and Applications
|
GLP 2 11 & 58 - Part 11
& 58
|
PDMA 11,
203 & 205 - Prescription
Drug Marketing
|
|
|
11
& 820 Electronic Record
and Quality Systems
|
|
|
|
The e-Newsletter of
What's New with CDER, CDRH & CBER
Distributed by the worlds
leader in Federal Regulations,
GMP Publications, Inc. & FDA.COM
Tel: 866-GXPNews (or 856-810-7331) Fax: 856-810-7339
http://www.gmppublications.com /
http://www.fda.com
John Cuspilich, Sr. Editor, GXPNews
If you would
like to advertise in this eNewsletter, call
856-810-1825
|